Drug-Coated Coronary Balloons in Different Clinical Scenarios

Coronary stents are the best treatment method ever accepted in the treatment of coronary artery stenoses. Due to some limitations and complications of stent use, the operators tried to find new solutions. Drug Coated Balloons (DCBs) have been accepted as a new method in the treatment of in-stent restenosis and small vessel disease. Furthermore, they have been used in the treatment of de novo coronary lesions, chronic total occlusions and bifucation lesions. But data is limited in the short and long term success of DCBs in all these clinical scenarios. In our study we aimed to investigate the procedural success and short and long term outcomes of DCB use in different clinical scenarios.

NCT Number	NCT06915597
Lead Sponsor	Kutahya Health Sciences University Collaborators: Pamukkale University, Memorial Bahçelievler Hospital, Bezmialem Vakif University, Dicle University, Ordu University, Adana City Training and Research Hospital, Marmara University, Trakya University, Kafkas University Health Research and Application Hospital, Selcuk University, Istanbul University - Cerrahpasa
Conditions	Coronary Arterial Disease (CAD)
Enrollment	1,500 participants
Start Date	2025-05-31
Primary Completion	2026-05-31 (estimated)
Study Completion	2026-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-13